ICON is a global provider of outsourced drug development services to biopharma, medical device, government, biosimilar and generic organisations. We offer a full range of clinical, consulting and commercial services that range from trial design to full study execution, and from clinical to post-market commercialisation. Our services are supported by in-depth therapeutic and regulatory expertise and market-leading technology and analytics. We are the only full service CRO that offers the knowledge, software and systems for adaptive trials. Further information is available at www.iconplc.com